IOVANCE BIOTHERAPEUTICS, INC. Derivative, Gain (Loss) on Derivative, Net
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Derivative, Gain (Loss) on Derivative, Net of $10.00 million for the 78-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2014-05-14
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2013-12-31 was -$20.00M, a 361.17% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2013-06-30 was $20.00M.
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for fiscal 2012 was $8.64M.
- IOVANCE BIOTHERAPEUTICS, INC. derivative, gain (loss) on derivative, net for fiscal 2011 was -$1.60M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 3 month as first filed | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month | Derivative, Gain (Loss) on Derivative, Net 12 month as first filed | Derivative, Gain (Loss) on Derivative, Net 54 month | Derivative, Gain (Loss) on Derivative, Net 57 month | Derivative, Gain (Loss) on Derivative, Net 60 month | Derivative, Gain (Loss) on Derivative, Net 63 month | Derivative, Gain (Loss) on Derivative, Net 66 month | Derivative, Gain (Loss) on Derivative, Net 69 month | Derivative, Gain (Loss) on Derivative, Net 72 month | Derivative, Gain (Loss) on Derivative, Net 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $10.00M 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | -$20.00M derived: 10-K 12 month − 3 quarters · filed 2014-03-28 | -$20.00M derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 | $10.00M 10-K · filed 2014-03-28 | |||||||||
| 2013-09-30 | $0.00 derived: 10-Q 72 month − 10-Q 69 month · filed 2013-11-14 | $20.00M derived: sum of 2 quarters · filed 2013-11-14 | $20.00M derived: sum of 3 quarters · filed 2013-11-14 | $27.66M derived: sum of 4 quarters · filed 2014-03-28 | $10.00M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $20.00M derived: 10-Q 69 month − 10-Q 66 month · filed 2013-10-23 | $20.00M derived: sum of 2 quarters · filed 2013-10-23 | $27.66M derived: sum of 3 quarters · filed 2014-03-28 | $29.26M derived: sum of 4 quarters · filed 2014-03-28 | $10.00M 10-Q · filed 2013-10-23 | |||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-10-23 | $7.66M derived: sum of 2 quarters · filed 2014-03-28 | $9.26M derived: sum of 3 quarters · filed 2014-03-28 | $6.09M derived: sum of 4 quarters · filed 2014-03-28 | -$10.00M 10-Q · filed 2013-10-23 | |||||||||
| 2012-12-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $9.26M derived: sum of 2 quarters · filed 2014-03-28 | $6.09M derived: sum of 3 quarters · filed 2014-03-28 | $8.64M 10-K · filed 2014-03-28 | -$8.64M 10-K · filed 2013-09-23 | -$10.00M 10-K · filed 2013-09-23 | ||||||||
| 2012-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$1.57M derived: sum of 2 quarters · filed 2013-11-14 | $975.70K 10-Q · filed 2013-11-14 | -$3.86M derived: sum of 4 quarters · filed 2013-11-14 | $2.34M 10-Q · filed 2013-01-25 | |||||||||
| 2012-06-30 | -$3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-23 | -$620.24K 10-Q · filed 2013-10-23 | -$5.46M derived: sum of 3 quarters · filed 2013-10-23 | -$1.91M derived: sum of 4 quarters · filed 2013-10-23 | $746.57K 10-Q/A · filed 2012-09-10 | |||||||||
| 2012-03-31 | $2.55M 10-Q · filed 2013-10-23 | -$2.55M 10-Q · filed 2012-05-15 | -$2.29M derived: sum of 2 quarters · filed 2013-10-23 | $1.26M derived: sum of 3 quarters · filed 2013-10-23 | $858.09K derived: sum of 4 quarters · filed 2013-10-23 | -$1.18M 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | -$4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | -$1.29M derived: sum of 2 quarters · filed 2013-09-23 | -$1.69M derived: sum of 3 quarters · filed 2013-09-23 | -$1.60M 10-K · filed 2013-09-23 | ||||||||||
| 2011-09-30 | $3.55M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-25 | $3.15M derived: sum of 2 quarters · filed 2013-01-25 | $3.24M 10-Q · filed 2013-01-25 | |||||||||||
| 2011-06-30 | -$398.56K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | -$304.60K 10-Q/A · filed 2012-09-10 | ||||||||||||
| 2011-03-31 | $93.95K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |